Log in to search using one of your social media accounts:

 

Cancer explained: Why men are more likely to be diagnosed than women

CANCER diagnoses are more common in men than women, figures have revealed. Express.co.uk is investigating find out why this could be the case.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news

Related Links:

This article is intended to facilitate differential diagnosis by a systematic description of relevant pathologies, notably with occupational etiology. Clinical findings of relevant diseases, i. e. of tuberculosis, chronic beryllium disease, sarcoidosis, lung cancer, malignant lymphoma, Epstein-Barr virus infection, and histoplasmosis are compared.Case history, imaging and laboratory tests have important diagnostic impact. But also invasive methods can be necessary in order to exclude and prove malignancy, infection or autoimmune disease. PMID: 29046010 [PubMed - as supplied by publisher]
Source: Pneumologie - Category: Respiratory Medicine Tags: Pneumologie Source Type: research
In this study, we developed a monoclonal antibody against the extracellular domain (ECD) of HER2 biomarker of breast cancer. For this purpose, the ECD-HER2 gene was amplified and cloned into an expression vector. Gene was generated in Escherichia coli BL21 (DE3) strain for expression of recombinant protein. The expressed protein was separated by SDS-PAGE and detected by anti-his monoclonal antibody in immunoblotting. Hybridoma cells were obtained by fusing myeloma cells with mouse spleen cells injected with recombinant ECD-HER2 and screened by ELISA for the production of monoclonal antibody. The results indicate that out o...
Source: Human Antibodies - Category: Biochemistry Tags: Hum Antibodies Source Type: research
Authors: Babic I, Nurmemmedov E, Yenugonda VM, Juarez T, Nomura N, Pingle SC, Glassy MC, Kesari S Abstract Immunotherapy is now at the forefront of cancer therapeutic development. Gliomas are a particularly aggressive form of brain cancer for which immunotherapy may hold promise. Pritumumab (also known in the literature as CLNH11, CLN-IgG, and ACA-11) was the first monoclonal antibody tested in cancer patients. Pritumumab is a natural human monoclonal antibody developed from a B lymphocyte isolated from a regional draining lymph node of a patient with cervical carcinoma. The antibody binds ecto-domain vimentin on t...
Source: Human Antibodies - Category: Biochemistry Tags: Hum Antibodies Source Type: research
We report on a 52-year-old woman with cardiomyopathy following chemotherapy and radiation therapy. The patient did not respond well to b-blockers and angiotensin-converting enzyme inhibitors. After the addition of exogenous phosphocreatine, the patient's cardiac condition improved significantly. PMID: 29038417 [PubMed - in process]
Source: Reviews in Cardiovascular Medicine - Category: Cardiology Tags: Rev Cardiovasc Med Source Type: research
According to a study published inOncotarget, palbociclib, normally used in the treatment of breast cancer, can be used to treat papillary thyroid carcinomas that are resistant to vemurafenib.Medical Xpress
Source: Society for Endocrinology - Category: Endocrinology Source Type: news
A new study in theBritish Journal of Cancerssuggests reports that the therapeutic strategy, commonly used to treat prostate cancer, may result in an increase of cardiovascular disease.Medical News Today
Source: Society for Endocrinology - Category: Endocrinology Source Type: news
No abstract available
Source: Oncology Times - Category: Cancer & Oncology Tags: News Source Type: research
No abstract available
Source: Oncology Times - Category: Cancer & Oncology Tags: News Source Type: research
No abstract available
Source: Oncology Times - Category: Cancer & Oncology Tags: News Source Type: research
No abstract available
Source: Oncology Times - Category: Cancer & Oncology Tags: Opinion Source Type: research
More News: Cancer | Cancer & Oncology | Health | Women